Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis

Journal of Neuroimmunology
Shuuichi MoriK Shigemoto


Muscle-specific kinase (MuSK), a receptor tyrosine kinase, is required for the formation and maintenance of neuromuscular junctions (NMJs). Although autoantibodies against MuSK have been demonstrated to cause myasthenia gravis (MG), the underlying pathogenic mechanism remains unclear because a major subclass of these antibodies is functionally monovalent. We investigated the pathogenic role of MuSK antibodies in the onset of MG in vivo and in vitro. Ultrastructural visualization of NMJs in paretic rabbits with MuSK antibodies indicated that postsynaptic membranes were preserved, despite a significant loss of complexity in the convoluted synaptic folds. In addition, an in vitro assay indicated that both divalent and monovalent antibodies from paretic rabbits could interfere with agrin-induced acetylcholine receptor (AChR) clustering in cultured myotubes. Furthermore, in the absence of agrin, divalent antibodies induced MuSK phosphorylation and accelerated downregulation of Dok-7, an essential intracellular MuSK binding protein, while monovalent antibodies inhibited agrin-induced phosphorylation of MuSK, thus demonstrating distinct molecular mechanisms underlying the MuSK dysfunction induced by these two types of antibodies. Take...Continue Reading


Sep 1, 1977·Journal of Pediatric Ophthalmology·S BerkovitzA Tenenbaum
Mar 30, 2004·Annals of Neurology·J McConvilleAngela Vincent
Oct 22, 2004·Human Molecular Genetics·Frédéric ChevessierDaniel Hantaï
Jan 26, 2005·Annals of Neurology·Hirokazu ShiraishiKatsumi Eguchi
Mar 25, 2006·The Journal of Clinical Investigation·K ShigemotoSeiji Matsuda
Jun 24, 2006·Science·Kumiko OkadaYuji Yamanashi
Aug 19, 2006·Science·David BeesonYuji Yamanashi
Oct 4, 2006·Neuron·Angela VincentKleopas A Kleopa
Nov 3, 2006·The Journal of Clinical Investigation·Bianca M Conti-FineHenry J Kaminski
Aug 28, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K OhtaM Ohta
Sep 18, 2007·Science·Marijn van der Neut KolfschotenPaul W H I Parren
Dec 22, 2007·Annals of the New York Academy of Sciences·K ShigemotoNaoki Maruyama
Dec 28, 2007·Muscle & Nerve·Jennifer A AndersonRicardo A Maselli
Apr 4, 2008·Annals of Neurology·Rebecca N ColeWilliam D Phillips
Jun 3, 2008·Brain : a Journal of Neurology·Maria Isabel LeiteAngela Vincent
Jun 24, 2008·Annals of the New York Academy of Sciences·Angela VincentNick Willcox


Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Maartje G HuijbersJan J Verschuuren
Dec 21, 2012·Annals of the New York Academy of Sciences·David P RichmanMark A Agius
Dec 21, 2012·Annals of the New York Academy of Sciences·Amelia EvoliEmanuela Bartocccioni
Jan 3, 2013·Annals of the New York Academy of Sciences·Jaap J PlompJan J Verschuuren
Jun 3, 2015·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Maartje G HuijbersJan J Verschuuren
May 29, 2016·Journal of Neuroimmunology·Melike KüçükerdenP Christadoss
Mar 5, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Canan UlusoyP Christadoss
Dec 30, 2014·Experimental Neurology·William D PhillipsAngela Vincent
Apr 28, 2016·Chemico-biological Interactions·Kinji OhnoMikako Ito
Aug 28, 2014·Current Opinion in Neurology·Stephen W ReddelWilliam D Phillips
Sep 3, 2013·Current Opinion in Neurology·Rozen Le Panse, Sonia Berrih-Aknin
Jan 30, 2018·Annals of the New York Academy of Sciences·Min YanLin Mei
Mar 19, 2019·Neurology. Neuroimmunology and Neuroinflammation·Maartje G HuijbersJan J Verschuuren
Mar 6, 2013·Journal of Anatomy·Inga KonecznyAngela Vincent
Feb 13, 2020·Immunological Medicine·Kazushiro TakataTatsusada Okuno
Feb 28, 2018·Frontiers in Immunology·Inga Koneczny
Aug 14, 2012·Expert Review of Clinical Immunology·Matthew N Meriggioli, Donald B Sanders
May 28, 2020·Frontiers in Immunology·Lucia S Borges, David P Richman
Mar 23, 2021·Proceedings of the National Academy of Sciences of the United States of America·Dana L E VergoossenMaartje G Huijbers

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.